BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20731246)

  • 1. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].
    Ołdakowska A; Marczyńska M
    Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
    Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
    Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
    Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine.
    Fernandes SJ; Slhessarenko N; Souto FJ
    Vaccine; 2008 Feb; 26(8):1032-7. PubMed ID: 18242796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of vaccination against hepatitis B in HIV infected children].
    Ołdakowska A; Marczyńska M; Szczepańska-Putz M; Kowalik-Mikołajewska B
    Przegl Epidemiol; 2004; 58 Suppl 1():129-33. PubMed ID: 15807171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
    Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T
    Vaccine; 2011 Apr; 29(16):2962-7. PubMed ID: 21329776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
    Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
    Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
    Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART.
    Pessoa SD; Miyamoto M; Ono E; Gouvêa AF; de Moraes-Pinto MI; Succi RC
    Vaccine; 2010 Feb; 28(6):1606-12. PubMed ID: 19961963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.